• HODL2MOONHODL2MOON
      ·16:37
      Hong Kong Stocks Are Trying to Stabilise. I’m Watching 2 Very Different Opportunities! After 2 difficult weeks, Hong Kong stocks have given investors a reason to look again at valuations. But I would not call a brief rebound a market bottom just yet. The Hang Seng Index dropped below 23,000 intraday on 22 October, while the Hang Seng TECH Index came under renewed pressure. By 29 October, the Hang Seng Index had recovered to around 23,100, but the Hang Seng TECH Index was still trading below 3,800 and fell again that day. To me, this is a reminder that a stabilising headline index does not mean every part of the market has recovered. Instead of trying to predict the next market-wide move, I would focus on two areas that have attracted attention: innovative drug and pharmaceutical outso
      2Comment
      Report
    • IsleighIsleigh
      ·16:02

      Hong Kong Has Not Bottomed Yet. But Smart Money Is Already Building a Barbell Trade.

      The Hang Seng has spent two weeks getting punished. HSI briefly fell below 23,000. HSTECH has fallen toward 3,770-3,800, its weakest level since September 2024. Then something interesting happened. The market did not suddenly buy everything. Money concentrated in two almost opposite trades: Biopharma and Mainland dividend banks. At first glance, that makes little sense. One is a high-growth innovation trade. The other is a defensive income trade. But I think the combination tells us exactly what investors are doing. They want upside, but they still do not trust the market. That is why my Hong Kong strategy is not simply: BUY THE DIP. It is: Build the barbell first. Buy the index later. 🔵 THE INDEX IS STABILISING. TECH IS NOT. This distinction matters. HSI has been trying to establish suppo
      251Comment
      Report
      Hong Kong Has Not Bottomed Yet. But Smart Money Is Already Building a Barbell Trade.
    • IsleighIsleigh
      ·16:02

      Hong Kong Has Not Bottomed Yet. But Smart Money Is Already Building a Barbell Trade.

      The Hang Seng has spent two weeks getting punished. HSI briefly fell below 23,000. HSTECH has fallen toward 3,770-3,800, its weakest level since September 2024. Then something interesting happened. The market did not suddenly buy everything. Money concentrated in two almost opposite trades: Biopharma and Mainland dividend banks. At first glance, that makes little sense. One is a high-growth innovation trade. The other is a defensive income trade. But I think the combination tells us exactly what investors are doing. They want upside, but they still do not trust the market. That is why my Hong Kong strategy is not simply: BUY THE DIP. It is: Build the barbell first. Buy the index later. 🔵 THE INDEX IS STABILISING. TECH IS NOT. This distinction matters. HSI has been trying to establish suppo
      251Comment
      Report
      Hong Kong Has Not Bottomed Yet. But Smart Money Is Already Building a Barbell Trade.
    • HODL2MOONHODL2MOON
      ·16:37
      Hong Kong Stocks Are Trying to Stabilise. I’m Watching 2 Very Different Opportunities! After 2 difficult weeks, Hong Kong stocks have given investors a reason to look again at valuations. But I would not call a brief rebound a market bottom just yet. The Hang Seng Index dropped below 23,000 intraday on 22 October, while the Hang Seng TECH Index came under renewed pressure. By 29 October, the Hang Seng Index had recovered to around 23,100, but the Hang Seng TECH Index was still trading below 3,800 and fell again that day. To me, this is a reminder that a stabilising headline index does not mean every part of the market has recovered. Instead of trying to predict the next market-wide move, I would focus on two areas that have attracted attention: innovative drug and pharmaceutical outso
      2Comment
      Report